Clinical Observations of Treating 40 Cases of Bronchial Asthma with Chuankezhi Injection

Objective: To prove the clinical therapeutic effect of acute and chronic bronchial asthma with Chuankezhi(CKZ) Injection. Methods: 40 cases of bronchial asthma, including inpatients and outpatients were selected, divided into the attack period group (20) and the relief period group (20). The former was intramuscularly injected CKZ injection 4mL, twice a day, 14 days being a course of treatment. The latter was intramuscularly injected CKZ injection 4mL, twice a day for 15～30 days and 2mL, every other day for 31～90 days; 90 days being a course of treatment. The symptoms and signs, such as asthma, cough, expectroation, pulmonary wheeze were observed. and pulmonary function, absolute eosinophilic granulocyte count and immunogobulin E were measured before and after treatment. Result: By the use of CKZ injection to treat bronchial asthma, the total effective rate amounted to 85% and obvious difference before and after treatment in the two groups ( P 0.01 ). In the attack period cases, the average drug action time (19.10±10.42)h; the average relief time ( 11.00 ±1.80) days. In the relief period group, recurrence reduce obviously. No significant untoward reaction was found. Conclusion: CKZ injection can be used for treatment of mild and moderate bronchial asthma.